F. Robert, Y. Landais, and G. Rousseau
um ether/EtOAc 9:1) yielded 11 (5 mg, 14% yield) as a yellow oil and 12
(24 mg, 54% yield) as a yellow oil. 11: 1H NMR (300 MHz, CDCl3): d=
7.44 (d, J=7.5 Hz, 1H), 7.41–7.24 (td, J=7.9, 1.5 Hz, 1H), 6.98 (t, J=
7.5 Hz, 1H), 6.83 (d, J=7.5 Hz, 1H), 6.20 (dd, J=9.4, 5.3 Hz, 1H), 6.14–
6.08 (m, 1H), 5.91–5.85 (m, 1H), 5.46 (d, J=9.4 Hz, 1H), 3.22 (s, 3H),
3.07–3.01 (td, J=7.7, 2.6 Hz, 1H), 2.36 ppm (dd, J=7.7, 5.6 Hz, 1H);
13C NMR (75.4 MHz, CDCl3): d=180.6, 141.7, 133.1, 128.5, 125.5, 124.7,
124.2, 123.6, 123.4, 122.7, 108.1, 48.5, 32.3, 26.5 ppm; IR (neat, NaCl): n=
3042, 2932, 1713, 1610, 1490, 1470, 1372, 1345 cmꢀ1; MS (EI): m/z: 211
(26) [M]+, 210 (100) [MꢀH]+; HRMS (ESI): m/z calcd for C14H13NONa
[M+Na]+: 234.0889; found: 234.0898. 12: 1H NMR (250 MHz, CDCl3):
d=7.41–7.22 (m, 6H), 7.15–7.04 (m, 3H), 6.87 (d, J=7.9 Hz, 1H), 6.61
(d, J=9.8 Hz, 1H), 6.53 (s, 1H), 5.62–5.52 (m, 2H), 3.26 ppm (s, 3H);
13C NMR (62.5 MHz, CDCl3): d=143.0, 136.7, 132.2, 131.7, 130.0, 129.4,
129.2, 128.7, 128.3, 127.9, 127.1, 125.5 125.3, 125.0, 123.1, 108.2, 55.0,
26.8 ppm; IR (neat, NaCl): n=3418, 3055, 2928, 1714, 1608, 1488, 1470,
1421 cmꢀ1; MS (EI): m/z: 299 (100) [M]+, 284 (10) [MꢀCH3]+; HRMS
(ESI): m/z calcd for C21H18NO [M+H]+: 300.1382; found: 300.1382.
113.6, 109.0, 104.5, 98.9, 55.5, 30.4, 29.7, 25.7, 22.8 ppm; IR (neat, NaCl):
n=3563, 2969, 1679, 1567 cmꢀ1; HRMS (ESI): m/z calcd for C16H18NO2
[M+H]+: 256.1332; found: 256.1330.
Compound 15: mCPBA (54 mg, 0.31 mmol, 1.5 equiv) was added to a so-
lution of 13a (45 mg, 0.2 mmol, 1 equiv) in CH2Cl2 (2 mL) at 08C. After
4 h at 08C, the reaction mixture was stirred for 16 h at RT. A saturated
aqueous solution of NaHCO3 was added and the mixture was extracted
three times with CH2Cl2.The combined organic extracts were washed
with brine, dried over MgSO4, and the solvent concentrated in vacuo. Pu-
rification by flash chromatography (silica gel, CH2Cl2/EtOAc 8:2) yielded
10 as a white solid (35 mg, 72%). M.p. 181–1838C; 1H NMR (300 MHz,
CDCl3): d=7.72 (d, J=8.3 Hz, 1H), 7.52 (t, J=7.9 Hz, 1H), 7.36 (d, J=
8.6 Hz, 1H), 7.25 (t, J=7.7 Hz, 1H), 3.90–3.83 (m, 1H), 3.72 (s, 3H), 3.60
(d, J=16.3 Hz, 1H), 3.54 (brs, 1H), 3.40 (brs, 1H), 2.80 (d, J=16.3 Hz,
1H), 1.34 ppm (d, J=7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): d=161.7,
142.5, 138.9, 129.5, 123.3, 122.0, 121.7, 119.5, 114.5, 56.2, 50.5, 29.8, 29.7,
24.6, 17.4 ppm; IR (KBr): n=2922, 1638, 1596, 1457, 1339, 1312,
1098 cmꢀ1; MS (EI): m/z (%): 241 (34) [M]+, 226 (29) [MꢀCH3]+, 212
(100) [MꢀNCH3]+, 198 (54) [MꢀCOCH3]+; HRMS (ESI): m/z calcd for
C15H16NO2 [M+H]+: 242.1175; found: 242.1178.
Compound 13a: Synthesized according to general procedure C from 7a
(211 mg, 1 mmol, 1 equiv), methyl iodide (0.3 mL, 2 mmol, 2 equiv), and
THF (10 mL). Purification by flash chromatography (silica gel, CH2Cl2/
EtOAc 97:3) afforded the 13a as a yellow viscous oil (150 mg, 67%).
1H NMR (250 MHz, CDCl3): d=7.76 (d, J=7.9 Hz, 1H), 7.54–7.52 (m,
1H), 7.40–7.38 (m, 1H), 7.28–7.24 (m, 1H), 5.95 (brs, 2H), 3.87–3.84 (m,
1H), 3.75 (s, 3H), 3.46–3.38 (m, 1H), 3.17–3.10 (m, 1H), 1.32 ppm (d, J=
7.0 Hz, 3H); 13C NMR (65 MHz, CDCl3): d=161.8, 144.7, 139.1, 129.3,
125.8, 124.5, 123.7, 122.0, 119.7, 114.7, 30.6, 29.9, 26.2, 22.9 ppm; IR
(neat, NaCl): n=3053, 2930, 1644, 1584, 1455, 1417, 1356, 1311 cmꢀ1; MS
(EI): m/z: 225 (10) [M]+, 210 (100) [M-CH3]+, 195 (23); HRMS (ESI):
m/z calcd for C15H16NO [M+H]+: 226.1231; found: 226.1230.
Compound 16a: Synthesized according to general procedure C from 7a
(42 mg, 0.2 mmol, 1 equiv) and benzaldehyde (50 mL, 0.40 mmol, 2 equiv)
in THF (2 mL). Purification by flash chromatography (silica gel, CH2Cl2/
EtOAc 6:4) afforded 16a as a pale yellow solid (38 mg, 60%). M.p. 182–
1838C; 1H NMR (300 MHz, CDCl3): d=7.81 (d, J=8.3 Hz, 1H), 7.56–
7.50 (m, 1H), 7.40–7.23 (m, 7H), 6.97 (dd, J=9.8, 1.5 Hz, 1H), 6.11 (dd,
J=10.0, 4.3 Hz, 1H), 4.65 (d, J=10.3 Hz, 1H), 3.76 (s, 3H), 3.16–
2.88 ppm (m, 3H); 13C NMR (75.4 MHz, CDCl3): d=162.0, 142.4, 138.8,
136.7, 136.1, 129.5, 128.3, 127.7, 126.8, 123.4, 123.3, 121.9, 121.6, 118.3,
114.4, 75.2, 40.9, 29.8, 23.0 ppm; IR (KBr): n=3386, 1643, 1597, 1454,
1093 cmꢀ1; MS (ESI): m/z: 340 (100) [M+Na]+, 318 (23) [M+H]+, 300
(15) [M+HꢀH2O]+; HRMS (ESI): m/z calcd for C21H19NO2Na
[M+Na]+: 340.1313; found: 340.1309.
By using (+)-bis[(R)-a-methylbenzyl]amine instead of diisopropylamine
led to enantioenriched 13a. Enantiomeric excess was measured by HPLC
analysis using a Chiralcel AD-H column (MeOH/EtOH/Et2NH 70:30:0.1,
flow rate 0.8 mLminꢀ1, l=276 nm): tminor =14.3 min, tmajor =30.1 min).
Compound 16b: Synthesized according to general procedure C from 7a
(42 mg, 0.2 mmol, 1 equiv) and isobutyraldehyde (35 mL, 0.40 mmol,
2 equiv) in THF (2 mL). Purification by flash chromatography (silica gel,
petroleum ether/EtOAc 1:1) afforded 16b (36 mg, 63%) as a yellow oil
(85:15 mixture of diastereomers that were assigned M for the major and
Compound 13b: Synthesized according to general procedure C from 7a
(42 mg, 0.2 mmol, 1 equiv) and allyl bromide (35 mL, 0.4 mmol, 2 equiv)
in THF (2 mL). Purification by flash chromatography (silica gel, CH2Cl2/
EtOAc 98:2) afforded 13b as a yellow oil (24 mg, 48%). 1H NMR
(300 MHz, CDCl3): d=7.75 (d, J=8.3 Hz, 1H), 7.57–7.50 (m, 1H), 7.42–
7.39 (m, 1H), 7.30–7.25 (m, 1H), 6.10–5.94 (m, 2H), 5.81–5.71 (m, 1H),
4.97 (m, 2H), 3.98–3.89 (m, 1H), 3.77 (s, 3H), 3.47–3.37 (m, 1H), 3.14–
3.03 (m, 1H), 2.61–2.30 ppm (m, 2H); 13C NMR (75.4 MHz, CDCl3): d=
161.4, 142.6, 138.9, 134.5, 129.2, 126.9, 126.8, 125.1, 124.0, 121.9, 119.4,
117.3, 114.6, 40.6, 35.3, 29.7, 26.4 ppm; IR (neat, NaCl): n=3415, 2928,
1633, 1588, 1462, 1416, 1316 cmꢀ1; MS (EI): m/z: 251 (5) [M]+, 210 (100)
[MꢀC3H5]+, 195 (42) [MꢀC4H8]+; HRMS (ESI): m/z calcd for C17H18NO
[M+H]+: 252.1382; found: 252.1389.
1
m for the minor one in the NMR data). H NMR (300 MHz, CDCl3): d=
7.71 (d, J=8.3 Hz , 1HM), 7.59 (d, J=8.3 Hz, 1Hm), 7.45–7.40 (m, 1HM+m),
7.27–7.24 (m, 1HM+m), 7.18–7.12 (m, 1HM+m), 6.90 (dd, J=10.0, 1.3 Hz,
1HM), 6.26 (dd, J=9.8, 4.1 Hz, 1HM+m), 5.87–5.81 (m, 1Hm), 4.17 (m,
1Hm), 3.65 (s, 3HM), 3.60 (s, 3Hm), 3.45–3.39 (m, 1Hm), 3.32 (t, J=6.0 Hz,
1HM+m), 3.16–3.07 (m, 1Hm), 2.99–2.80 (m, 2HM+m), 2.66–2.60 (m, 1HM),
1.85–1.74 (m, 1HM+m), 1.14 (d, J=6.8 Hz, 3Hm), 0.96 (d, J=6.8 Hz, 3Hm),
0.92 (d, J=6.8 Hz, 3HM), 0.85 ppm (d, J=6.8 Hz, 3HM); 13C NMR
(75.4 MHz, CDCl3): d=162.0 (M), 161.1 (m), 141.1 (m), 139.0 (m), 138.8
(M), 137.4 (M),136.6 (M), 129.6 (m), 129.4 (M+m), 129.2 (m), 128.3 (m),
123.6 (m), 123.4 (M), 121.8 (M), 121.5 (M), 121.4 (M+m), 119.2 (m),
118.3 (M), 114.7 (m), 114.4 (M), 80.3 (m), 77.4 (M), 38.6 (m), 36.8 (M),
32.4 (m), 30.4 (M), 29.8 (M), 29.6 (m), 27.0 (m), 21.4 (M), 20.2 (m), 19.8
(M), 19.4 (m), 17.0 (M); IR (neat, NaCl): n=3416, 2959, 1642, 1618,
1597, 1460 cmꢀ1; MS (ESI): m/z: 306 (100) [M+Na]+, 284 (63) [M+H]+;
HRMS (ESI): m/z calcd for C18H21NO2Na [M+Na]+: 306.1470; found:
310.1476.
Compound 13c: Synthesized according to general procedure C from 7a
(42 mg, 0.2 mmol, 1 equiv) and methoxymethyl chloride (MOMCl; 30 mL,
0.4 mmol, 2 equiv) in THF (2 mL). Purification by flash chromatography
(silica gel, petroleum ether/EtOAc 1:1) afforded 13c as a yellow oil
(15 mg, 30%). 1H NMR (250 MHz, CDCl3): d=7.83 (d, J=8.3 Hz, 1H),
7.56–7.51 (m, 1H), 7.41–7.26 (m, 2H), 6.11 (brs, 2H), 4.15–4.06 (m, 1H),
3.76 (s, 3H), 3.68 (dd, J=9.0, 4.1 Hz, 1H), 3.53–3.44 (m, 2H), 3.32 (s,
3H), 3.19–3.09 ppm (m, 1H); 13C NMR (62.5 MHz, CDCl3): d=161.4,
140.2, 138.8, 129.3, 127.6, 126.0, 125.7, 124.1, 121.9, 119.7, 114.5, 77.0,
59.2, 36.7, 29.7, 26.3 ppm; IR (neat, NaCl): n=2926, 1633, 1596, 1461,
1417, 1314, 1192, 1110 cmꢀ1; MS (ESI): m/z: 256 (100) [M+H]+, 239 (14)
[MꢀCH3]+; HRMS (ESI): m/z calcd for C16H18NO2 [M+H]+: 256.1338;
found: 256.1341.
Compound 16c: Synthesized according to general procedure C from 7a
(42 mg, 0.2 mmol, 1 equiv) and pivaladehyde (44 mL, 0.4 mmol, 2 equiv)
in THF (2 mL). Purification by flash chromatography (silica gel, petrole-
um ether/EtOAc 1:1) afforded 16c as a pale yellow solid (36 mg, 61%).
M.p. 96–988C; 1H NMR (250 MHz, CDCl3): d=7.77 (d, J=8.3 Hz, 1H),
7.51 (t, J=8.3 Hz, 1H), 7.36–7.33 (m, 1H), 7.25–7.20 (m, 1H), 6.93 (dd,
J=9.8, 2.3 Hz, 1H), 6.30 (dd, J=9.8, 3.8 Hz, 1H), 3.74 (s, 3H), 3.47 (d,
J=3.8 Hz, 1H), 3.10–2.91 (m, 2H), 2.83–2.75 (m, 1H), 1.01 ppm (s, 9H);
13C NMR (62.5 MHz, CDCl3): d=161.9, 139.9, 138.8, 136.4, 129.4, 123.9,
123.3, 121.8, 121.0, 118.2, 114.3, 81.4, 36.1, 35.7, 29.8, 27.0, 21.9 ppm; IR
(KBr): n=3424, 2954, 2868, 1645, 1616, 1598, 1460, 1414, 1364,
1315 cmꢀ1; MS (ESI): m/z: 320 (100) [M+Na]+, 298 (77) [M+H]+, 210
Compound 13d: Synthesized according to general procedure C from 7b
(48 mg, 0.2 mmol, 1 equiv) and methyl iodide (25 mL, 0.4 mmol, 2 equiv)
in THF (2 mL). Purification by flash chromatography (silica gel, petrole-
um ether/EtOAc 8:2) afforded 13d as
a yellow oil (21 mg, 42%).
1H NMR (200 MHz, CDCl3): d=7.66 (d, J=8.6 Hz, 1H), 6.87–6.81 (m,
2H), 5.94 (brs, 2H), 3.91 (s, 3H), 3.84–3.75 (m, 1H), 3.71 (s, 3H), 3.42–
3.31 (m, 1H), 3.14–3.03 (m, 1H), 1.30 ppm (d, J=7.0 Hz, 3H); 13C NMR
(50 MHz, CDCl3): d=162.0, 160.4, 144.5, 140.5, 129.0, 125.6, 123.6, 122.5,
11170
ꢁ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2009, 15, 11160 – 11173